
usd pm et
summari compani one largest employe benefit organ
primari focu health plan pharmaci benefit
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
stock trade
oper revenu vs
full quarter
sinc decemb express script
acqusit pharmaci revenu
total vs medic
membership yoy strong growth
risk membership total
essenti chang ci largest
categori non-risk/servic
despit low membership growth risk price
oper incom compar yoy
due acquisit also
oper margin first nine
month
period result express
deal ci total debt
around acquisit
addit number share outstand
grown yoy
signific amount legaci client
discontinu relationship follow
acquisit ci expect loss
custom mainli coventri
around revenu loss
ci durabl posit commerci health
plan posit long term revenu growth
outlook view remain neutral
share due express script deal
think integr larg pbm achiev
forecast synergi challeng make
earn outlook unclear next two
year polit risk relat pbm drug rebat
also mount view could result
new regul disrupt busi
ci util combin in-hous
pbm optumrx prior deal
achiev strong result
medic cost ratio basi point
given success question
whether ci purchas major pbm
worth larg amount sharehold dilut
debt requir
target ep estim
-- ci histor forward price-to-earnings averag due
integr risk regulatori scrutini
around pbm drug rebat risk
view includ rise medic util cost
trend also think ci high exposur
commerci membership put high risk
potenti econom contract
competit intens manag care ci taken
signific leverag integr risk associ
billion acquisit express script
drug price rebat model use pbm come
intens polit scrutini ci also
above-averag risk membership loss
econom slowdown view custom base
mostli group commerci contract lose
membership materi faster medicar medicaid
health plan unemploy rise
feb ep estim base cfra oper earn
histor earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview fifth largest employe benefit organ term revenu
compani provid health care product servic well group life accid disabl
offer broad varieti benefit plan includ medic dental behavior health pharmaci
servic product medic product includ consum direct health plan cdhp hmo prefer
provid organ ppo among other health care product servic purchas
risk-bas plan custom pay fix premium carri risk health benefit
cost exceed premium revenu administr servic aso plan arrang
manag custom access health network custom self-fund medic cost aso
custom also sometim purchas stop-loss insur maximum exposur
medic cost limit exchang insur premium
decemb roughli medic custom base
approxim risk-bas custom pay premium servic custom pay
fee administr claim access network gener self-fund
larg major medic custom commerci custom commerci
million decemb total medic membership commerci busi
compris sever type custom account includ nation account multi-st
employ -base full-tim employe typic purchas aso fund
solut market account employ gener -base full-tim
employe purchas risk-bas aso plan select account employ gener
elig employe purchas aso stop loss insur coverag risk-bas plan
commerci medic membership grew grew
addit commerci busi provid manag care servic government-sponsor
custom govern segment compris approxim medic membership
decemb gener provid risk-bas plan compani govern segment offer
medicar advantag plan medicar part plan medicaid plan contract state
texa medicar supplement plan govern medic membership grew
beyond tradit medic benefit also provid benefit plan cover pharmaceut
behavior health dental group disabl life insur number custom
particip pharmaci benefit grew million million primarili
due addit custom gain complet express script combin
decemb acquisit express script pharmaci benefit manag came cost
approxim billion cash roughli equiti dilut pre-exist holder due
new equiti consider receiv express script holder primarili result express script
deal debt increas billion decemb billion decemb
addit health care benefit gener invest incom insur float
premium revenu paid advanc risk-bas plan yet paid medic claim
oper expens decemb held roughli billion cash
invest gener net invest incom billion
competit landscap accord insur inform institut roughli health
insur compani unit state estim rank fourth total medic
membership behind aetna own
gener compet nation for-profit manag care organ well
region local health plan provider-sponsor plan
financi trend oper revenu exclud invest incom increas billion
billion reflect three-year compound annual growth rate compound-annual-growth-rate
adjust pre-tax incom per share increas reflect
three-year compound-annual-growth-rate
chairman board
senior vice-president tax chief
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
ci slightli overvalu usd
bullish sinc octob technic indic ci
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
back topic headlin risk democrat
took control hous repres
novemb mid-term elect
result chang dynam
washington republican
domin preced two year
coupl key democrat candid
becom law would like lower
averag rate health care servic
henc substanti advers impact firm
sub-industri howev think
almost-zero chanc becom realiti
near futur
anoth headlin risk potenti repeal
afford act instig
judg texa rule
unconstitut oppon
appeal decis current expect
upheld upon appeal although
decis could take coupl year
reach repeal
expect neg impact health care
servic benefit
increas insur coverag past
sever year
year-to-d septemb
increas composit
 health servic
increas vs decreas
 composit index
outlook health care servic
sub-industri next year posit
base key assumpt
economi current late stage
econom cycl mean expect
slowdown econom growth mani
firm within sub-industri like
see sustain demand servic even
face weaker econom condit
signific advers chang
oper competit environ
sub-industri recent pressur
headlin risk relat legisl
regulatori propos medicare-for-al
amazon potenti disrupt health
care sector headlin unlik
evolv real threat profit
health care servic firm near
futur analysi
sub-industri under-perform broader
market recent due pressur uniqu
benefit manag pbm hurt
lower level drug price inflat
increas pressur third parti payer
partial allevi high
firm issu find
see opportun health care servic
firm address take advantag
recent pressur face
exampl major pbm merg
major insur off-set pressur
aet ci acquir express script
esrx lab servic provid
opportun acquir smaller lab gain
scale smaller lab like falter
pressur continu signific
base index
five-year market price perform
note sector sub-industri inform base
past perform indic futur perform
reli upon
laboratori corpor america
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
drop target ep estim --
ci histor forward price-to-earnings averag due integr risk regulatori
scrutini around drug rebat pbm rais ep estim
ep vs beat consensu
oper revenu versu prior year period
ci report first full quarter follow decemb purchas
script ci gener revenu pharmaci versu
adjust ep yoy howev inorgan growth off-set share
dilut higher interest cost new debt transit client despit
histor low valuat remain cautiou ci share concern
synergi improv competit deriv deal
outweigh capit cost especi given view polit uncertainti
around pbm busi model increas /colin scarola
pm et cfra maintain rate manag firm follow medicar
yesterday hous democrat unveil medicar
act drove sharp stock declin manag care firm
maintain ep outlook invest rate stock howev
think bill similar one highli unlik becom law bill
would move virtual citizen medicare-lik program elimin
privat insur abil compet cover basic health benefit
view sweep chang like requir broad support think
lack million american would lose employee-sponsor plan
bill detail larg tax increas think would face
financ unlik bill increment chang system
narrowli pass despit larg democrat major chamber
far today partisan balanc senat berni sander
introduc similar bill ultim impact manag care
analyst research note compani news
et cfra keep hold opinion share cigna corpor
lift price target ep
estim -- ci histor forward price-to-earnings averag due
integr risk high leverag rais ep estim
maintain start ep vs
yoy beat consensu oper revenu exclud
invest incom grew driven
decemb purchas pharmaci benefit manag express script
deal major driver earn increas ci also saw
yoy organ growth premium health plan oper revenu
gross margin health plan servic improv impress bp
yoy despit ci histor low valuat remain cautiou share
concern target synergi deal may materi
nearli one year remov close sg expens rise
sequenti rather move downward /colin scarola
pm et cfra maintain posit outlook manag health
industri share larg health plan provid
under-perform major indic week includ
ci sinc septemb compar drop
 think partial driven neg sentiment
speaker hous week announc impeach inquiri
presid trump view reaction due mani investor believ
impeach republican presid tip balanc power increas
odd democrat medicare-for-al propos becom law
elimin privat health plan think reaction misguid though
recent kaiser famili foundat poll estim voter
support elimin privat health plan favor even among
democrat voter major includ democrat speaker prefer
build implement accordingli maintain
posit outlook industri /colin scarola
pm et cfra keep hold opinion share cigna corpor
lift target ep estim ci
histor forward price-to-earnings averag due integr risk high
leverag rais ep estim keep
ep vs beat consensu oper revenu
vs second full quarter
follow decemb purchas express script ad quarterli
ci pharmaci revenu deal drove yoy jump oper incom
interest expens roughli new debt
share count increas use fund deal adjust ep
grew yoy note larg manag care peer
histor low valuat remain cautiou ci concern
synergi improv competit deal outweigh
capit cost /colin scarola
et cfra maintain strong buy opinion share
corpor share pharmaci benefit manag pbm
includ ci insur trade pre-market today
news trump administr end pursuit elimin rebat
collect pbm mostli pass insur
expect elimin rebat sever impact profit
pbm move would certainli caus short-term industri
friction compani would modifi contract process
respons possibl rebat elimin also seem weigh
heavili share pbm past year on-going debat
rise health care price drug industri frequent point pbm
industri key sourc high drug price rebat elimin
tabl expect trump administr turn focu away
pbm back toward drug industri /kevin huang cfa
et cfra keep hold opinion share cigna corpor
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim ci earn
usd quarter fiscal year ci
announc earn per share usd repres
total revenu estim fiscal year
analyst estim ci earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
